Home » Topics » BioWorld Science

BioWorld Science
RSS

GPA-500 reduces tumor growth in models of enzalutamide-resistant prostate cancer

Dec. 5, 2018

DCB-HDG2-411 shows promising preclinical activity for Hh pathway-driven cancers

Dec. 5, 2018

GRB10 identified as a novel therapeutic target in AML

Dec. 5, 2018

Novel degraders of IRAK-4 demonstrate promising preclinical activity in ABC-DLBCL models

Dec. 5, 2018

New PROTAC DT-2216 shows promising preclinical activity against BCL-X(L)-dependent tumors

Dec. 5, 2018

ALLO-715 CAR T cells exhibit antitumor potency in in vitro and in vivo models of R/R MM

Dec. 5, 2018

University of Louisville stem cell-derived exosomes for cancer

Dec. 5, 2018

aTyr Pharma initiates phase Ib/IIa study of ATYR-1923 in patients with pulmonary sarcoidosis

Dec. 5, 2018

University of Pennsylvania divulges anti-PF-4 antibodies

Dec. 5, 2018

Calygene Biotechnology patents new ML1 antagonists

Dec. 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...